Representative before the EPO

Company dna proteome sciences plc
no operation time available
Headquarter in Cobham and 3 offices
active in Legal Services

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 4 EP applications Daniela Gill-Carey has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after June 18, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12731142

MATERIALS AND METHODS FOR DETERMINING SENSITIVITY POTENTIAL OF COMPOUNDS

IPC classification:
G01N 33/50, C07K 14/00
Agent:
Multiple attorneys, Proteome Sciences plc
Agent:
Joanna Elizabeth Cripps, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12756810

MATERIALS AND METHODS FOR DETERMINING SENSITIVITY POTENTIAL OF COMPOUNDS

IPC classification:
G01N 33/68, G01N 33/50
Agent:
Multiple attorneys, Proteome Sciences plc
Agent:
Daniela Gill-Carey, Novartis Pharma AG
Agent:
Joanna Elizabeth Cripps, Mewburn Ellis LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12768999

FUSION PROTEINS FOR TREATING METABOLIC DISORDERS

IPC classification:
A61K 47/48, C07K 14/50
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Agent:
Daniela Gill-Carey, Novartis Pharmaceuticals UK Limited
Status:
GRANT OF PATENT INTENDED
EP14190691

Casein kinase 1delta (CK1delta) inhibitors

IPC classification:
A61K 31/506, A61K 31/4439, A61K 31/437, A61K 31/00, A61P 25/28
Agent:
Multiple attorneys, Proteome Sciences plc
Agent:
Mark Gibson, Sagittarius IP
Status:
The patent has been granted

Please Sign in to use this feature